BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2137998)

  • 1. Usefulness of echocardiographic left ventricular hypertrophy and silent ischemia in predicting new cardiac events in elderly patients with systemic hypertension or coronary artery disease.
    Aronow WS; Epstein S; Koenigsberg M
    Angiology; 1990 Mar; 41(3):189-93. PubMed ID: 2137998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Arrhythmogenicity in left ventricular hypertrophy in mild to moderate arterial hypertension].
    Franchi F; Michelucci A; Padeletti L; Monopoli A; Fabbri G; Cersosimo RM; Mezzani A
    G Ital Cardiol; 1992 Aug; 22(8):905-18. PubMed ID: 1478391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of echocardiographic left ventricular ejection fraction and silent myocardial ischemia in predicting new coronary events in elderly patients with coronary artery disease or systemic hypertension.
    Aronow WS; Epstein S; Koenigsberg M
    Am J Cardiol; 1990 Mar; 65(11):811-2. PubMed ID: 2316467
    [No Abstract]   [Full Text] [Related]  

  • 4. [Prognostic implications of left ventricular hypertrophy in arterial hypertension].
    Kannel WB
    Arch Mal Coeur Vaiss; 1990 Dec; 83 Spec No 4():11-21. PubMed ID: 2150470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Detection of cardiac risk in hypertensive patients with left heart hypertrophy].
    Schulte KL; Meyer-Sabellek W; Liederwald K; Eisenhut C; Distler A; Gotzen R
    Z Kardiol; 1991; 80 Suppl 1():37-40. PubMed ID: 1827230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Concentric left ventricular hypertrophy in patients with hypertension. When should ventricular hyperexcitability be searched for?].
    Galinier M; Massabuau P; Puel J; Fourcade J; Fauvel JM; Bounhoure JP
    Arch Mal Coeur Vaiss; 1990 Jul; 83(8):1107-10. PubMed ID: 1701985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regression of echocardiographic left ventricular hypertrophy after 2 years of therapy reduces cardiovascular risk in patients with essential hypertension.
    Pierdomenico SD; Lapenna D; Cuccurullo F
    Am J Hypertens; 2008 Apr; 21(4):464-70. PubMed ID: 18369364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myocardial perfusion imaging with thallium-201 to assess left ventricular hypertrophy and regional ischaemia in hypertensive patients.
    Folmer SC; Wieling W; Dunning AJ
    Eur J Clin Invest; 1981 Aug; 11(4):291-7. PubMed ID: 6457747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of chronic hypertension and left ventricular hypertrophy on the incidence of sudden cardiac death after coronary artery occlusion in conscious dogs.
    Koyanagi S; Eastham C; Marcus ML
    Circulation; 1982 Jun; 65(6):1192-7. PubMed ID: 6210460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Arrhythmia risk and noninvasive markers in hypertensive left ventricular hypertrophy].
    Akdeniz B; Güneri S; Badak O; Aslan O; Tamci B
    Anadolu Kardiyol Derg; 2002 Jun; 2(2):121-9; AXVII. PubMed ID: 12134537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Arterial hypertension, left ventricular hypertrophy and arrhythmias].
    González Maqueda I
    Rev Esp Cardiol; 1991 Nov; 44(9):586-98. PubMed ID: 1723211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypertensive heart disease: relationship of silent ischemia to coronary artery disease and left ventricular hypertrophy.
    Yurenev AP; DeQuattro V; Devereux RB
    Am Heart J; 1990 Oct; 120(4):928-33. PubMed ID: 2145735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What is the role of silent coronary artery disease and left ventricular hypertrophy in the genesis of ventricular arrhythmias in men with essential hypertension?
    Szlachcic J; Tubau JF; O'Kelly B; Ammon S; Daiss K; Massie BM
    J Am Coll Cardiol; 1992 Mar; 19(4):803-8. PubMed ID: 1531991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determinants of left ventricular hypertrophy in arterial hypertension.
    Heinemann G; Wallrabe D
    Cor Vasa; 1990; 32(1):19-25. PubMed ID: 2140316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ischemia during ambulatory monitoring as a prognostic indicator in patients with stable coronary artery disease.
    Mulcahy D; Husain S; Zalos G; Rehman A; Andrews NP; Schenke WH; Geller NL; Quyyumi AA
    JAMA; 1997 Jan 22-29; 277(4):318-24. PubMed ID: 9002495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Myocardial hypertrophy and coronary insufficiency as a cause of arrhythmia in patients with hypertension].
    Israpilov MM; Gerashchenko IuS; Fofanova TV; Iurenev AP
    Ter Arkh; 1999; 71(4):37-40. PubMed ID: 10358861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of sudden cardiac death in never previously treated patients with essential hypertension: long-term follow-up.
    Saadeh AM; Jones JV
    J Hum Hypertens; 2001 Oct; 15(10):677-80. PubMed ID: 11607796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of heart failure hospitalizations with combined electrocardiography and echocardiography criteria for left ventricular hypertrophy.
    Gerdts E; Okin PM; Boman K; Wachtell K; Nieminen MS; Dahlöf B; Devereux RB
    Am J Hypertens; 2012 Jun; 25(6):678-83. PubMed ID: 22456225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Signal averaged ECG in different patterns of left ventricular hypertrophy and geometry in hypertension.
    Wojszwiłło A; Łoboz-Grudzień K; Jaroch J
    Kardiol Pol; 2003 May; 58(5):335-43. PubMed ID: 14523481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validity of the ECG diagnosis of left ventricular hypertrophy in normotensive and moderately hypertensive men when using the echocardiographic assessment of left ventricular mass index as reference.
    Otterstad JE; Froeland G; Wasenius AK; Knutsen KM; Michelsen S; Stugaard M
    J Hum Hypertens; 1991 Apr; 5(2):101-6. PubMed ID: 1830106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.